- Home
- ENVB vs IBG Comparison
ENVB vs IBG Comparison
Compare ENVB & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ENVB | IBG |
|---|---|---|
| Founded | 1994 | 2018 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.3M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | ENVB | IBG |
|---|---|---|
| Price | $2.06 | $3.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | 66.7K | ★ 159.7K |
| Earning Date | 03-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.04 | $3.27 |
| 52 Week High | $54.00 | $49.25 |
Technical Indicators
Market Signals| Indicator | ENVB | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 26.81 | 63.57 |
| Support Level | $2.04 | $3.79 |
| Resistance Level | $4.67 | $5.29 |
| Average True Range (ATR) | 0.28 | 0.55 |
| MACD | -0.11 | 0.23 |
| Stochastic Oscillator | 3.19 | 69.48 |
Price Performance
Historical ComparisonAbout ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.